Cortisol Calm Matrix
Natural health product licensed in Canada
- Other names
- Core Cortisol Support, Cortico-Calm Matrix, Cortisol Clamp, Cortisol Matrix, Cyto Cortisol Calm, Foundational Cortisol Support
- Licence holder
- Cyto-Matrix Inc.
- NPN or DIN-HM
- 80113115
- Status
- Active licence
- Licence date
- 24 September 2021
- Revision date
- 28 August 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Magnolia officinalis Rehder & E.H.Wilson: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Phellodendron amurense Rupr.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide gamma-aminobutyrique Source : Acide 4-aminobutanoïque | 100 mg | Not calculated |
| Withania somnifera Source : Withania somnifera - racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 312.5 mg Potency : 0.05 % Withaferin A | 62.5 mg | Not calculated |
| Magnésium Source : Bisglycinate de magnésium | 25 mg | 50,000 µg |
| Inositol Source : Inositol | 50 mg | Not calculated |
| Magnolia officinalis Source : Écorce (branche) Potency : 8.5 % Honokiol | 34.375 mg | Not calculated |
| Phellodendron amurense Source : Écorce (branche) Potency : 2.5 % Berberine | 11.25 mg | Not calculated |
| Withania somnifera Source : Withania somnifera - racine Potency : 32 % Withania oligosaccharides | Not specified | Not calculated |
| Withania somnifera Source : Withania somnifera - racine Potency : 10 % Withanolide glycosides | Not specified | Not calculated |
Non-medicinal ingredients
Hypromellose, Cellulose microcristalline, Stéarate de magnésium, Acide citrique, Amidon prégélatinisé, Dioxyde de silicium, Amidon de maïs
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in the development and maintenance of bones and teeth and maintain proper muscle function and tissue formation. Helps maintain proper muscle function and tissue formation. Helps to maintain heart muscle function. Helps to maintain normal electrolyte balance. Helps to maintain proper muscle function, including the heart muscle. Provides/Source of/An electrolyte (for the maintenance of good health). Helps to temporarily promote relaxation. Helps reduce the symptoms of stress, such as fatigue, sleeplessness, irritability, and inability to concentrate. Helps reduce cortisol and C-reactive protein levels, the biomarkers of physical stress. Helps to temporarily relieve symptoms of stress.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80113115
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging